Lamotrigine in Rett syndrome: treatment experience from a pilot study.
This open pilot study was performed to evaluate the effect of Lamotrigine (LTG) in girls with Rett syndrome (RS) regarding seizure frequency, effect on gross motor dyspraxia and safety. Twelve girls with either the classical form of RS or the milder form fruste variants were included. The effect on epilepsy was evaluated as seizure frequency, motor performance (video comparison) and safety at clinical check up. The dosage of LTG was individualized and related to concomitant anti-epileptic drugs. Two of three girls with epilepsy responded relatively well to treatment, and for one of them even bad tantrums disappeared. LTG was useful in another four girls who became happier, more alert, more able to concentrate, and improved in contacting. Only mild adverse reactions as rash and tremor were seen. It is concluded that LTG could be worth trying as an adjunct in girls with RS, being aware of possible adverse reactions and no effect at all.
Stenbom
Y
Y
Department of Child and Adolescent Psychiatry, Huddinge University Hospital, Sweden.
Tonnby
B
B
Hagberg
B
B
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000209:etiology; D005260:Female; D006801:Humans; D015994:Incidence; D000077213:Lamotrigine; D010865:Pilot Projects; D011597:Psychomotor Performance / Q000187:drug effects; D015518:Rett Syndrome / Q000145:classification / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012449:Safety; D014227:Triazines / Q000627:therapeutic use*
D000927:Anticonvulsants; D014227:Triazines; D000077213:Lamotrigine